Caldwell IP partnered with MIT Enterprise Forum to host a virtual panel discussion on the future of healthcare. With the advent of numerous technological innovations spurred on by Covid-19, the healthcare industry is ripe for systemic change. Caldwell IP’s Patent Attorney & Chair of Life Sciences, Katie Rubino, invited a handful of innovators who are a part of this digital revolution to share on how they aim to fix a fractured healthcare system through innovation.
MIT Enterprise Forum (MITEF) is a global thought-leadership organization affiliated with the Massachusetts Institute of Technology. With a global network of dedicated professionals, MITEF informs, connects and coaches technology entrepreneurs to accelerate their growth in becoming industry-leading technology companies.
Nicholas Oddo is Co-Founder and Inventor at Aires Medical. Aires Medical is a venture capital funded company that makes high flow oxygen therapy and ventilation products to help improve quality of life for people with lung disease.
Nirav is the CEO and founder of Cevona. He is passionate about enabling better healthcare experiences for patients and providers. Prior to Cevona, Nirav co-founded Carium, a healthcare technology venture. He has built a successful career as an entrepreneur across multiple industry verticals, bringing together high-performing teams and leveraging technology as an enabler of transformation. Nirav holds a B.S. in Electrical Engineering from the Illinois Institute of Technology and a M.S. in Electrical Engineering from the University of Minnesota.
Peter Vranes is a Chemical Engineer and serial entrepreneur. Prior to Nutromics, Peter founded Biocore Technologies and lead the team with the development and commercialization of several natural cosmeceutical skincare brands that were distributed in 1,500 retailers throughout Australia. The company was successfully sold in 2013.
Reginald is the CEO and Founder of Rubix LS. He is passionate about using innovation at a greater scale to change how health outcomes can be realized through patient product and service innovation. With a background in mechanical engineering from Harvard Medical, many of his research pursuits involve the development of regenerative metals to target specific diseases such as Multiple Sclerosis for Myelin regeneration, ALS, PLS, PKAN and much more focused in rare and infectious diseases.